Block Drug Co. introduces PerioGlas for the treatment of infrabony defects caused by periodontal disease. The bioactive ceramic material is available to dental professionals as a result of an agreement between Block Drug and U.S. Biomaterials Corp.
- PerioGlas bonds to both bone and soft tissue, regenerates bone rapidly, adapts to the defect, initiates a chemical bond that inhibits epithelial downgrowth, and effectively repairs and restores the periodontium.
- When mixed with a few drops of sterile water, the material becomes ready to use within seconds.
- The biocompatible PerioGlas will not float out of the defect site and is inaffected by adjacent suctioning.
For more information, contact Block Drug, 257 Cornelison Ave., Jersey City, NJ 07302-9988; (201) 434-3000.
